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Background: COVID-19 was declared a pandemic on March 11, 2020. Given that the severe shortage of hospital beds has led
to early discharge and insufficient patient education on home care routines and isolation protocols, the close follow-up of patients
and their immediate relatives is an integral part of transitioning from hospital care to home care for patients with COVID-19.
Objective: We designed the Tele-COVID-19 prospective cohort to follow-up with COVID-19 patients in Tehran, Iran, and
improve health care delivery and the recording of postdischarge patients’ clinical profiles.
Methods: All adult patients who were admitted to the COVID-19 wards of teaching hospitals in Tehran, Iran were eligible to
participate in this cohort study. At baseline, patients were recruited from 4 major hospitals from March 9, 2020 to May 20, 2020.
Telephone follow-ups, which were led by volunteer medical students, were conducted on postdischarge days 1-3, 5, 7, 10, and
14. We collected data on a range of sociodemographic, epidemiological, and clinical characteristics by using a standard
questionnaire.
Results: Of the 950 patients with confirmed COVID-19 who were approached, 823 (response rate: 86.6%) consented and were
enrolled into the cohort. Of the 823 participants, 449 (54.5%) were male. The mean age of participants was 50.1 years (SD 12.6
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years). During the initial data collection phase, more than 5000 phone calls were made and over 577 reports of critical patients
who were in need of urgent medical attention were recorded.
Conclusions: The Tele-COVID-19 cohort will provide patients with sufficient education on home care and isolation, and medical
advice on care and the proper use of drugs. In addition, by preventing unnecessary hospital returns and providing information on
household SARS-CoV-2 transmission as early as possible, this cohort will help with effective disease management in
resource-limited settings.
International Registered Report Identifier (IRRID): DERR1-10.2196/23316
(JMIR Res Protoc 2021;10(2):e23316) doi: 10.2196/23316
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Introduction
The COVID-19 disease, which is caused by the SARS-CoV-2
virus, was declared a pandemic on March 11, 2020. Based on
the existing evidence, the risk of infection appears to be
relatively low for the general population. However, older people,
immunocompromised people, and those with underlying health
conditions, such as cardiovascular diseases, are at an elevated
risk of morbidity and mortality [1]. As of December 11, 2020,
71,088,688 patients with confirmed COVID-19 and 1,595,096
deaths have been reported across the globe [2]. To date, effective
treatment options for COVID-19 are unavailable. However,
more than 2500 trials and studies are being conducted worldwide
to develop and evaluate different therapeutic options for
COVID-19 [3]. Implementing swift, community-centered
preventive measures, providing timely diagnoses, treatments,
contact tracing services, and methods for the successful isolation
of patients at home, and reducing the household transmission
of the virus among infected patients’ close contacts have been
at the core of recommended strategies for combating the disease
[4-6].
Despite the extensive worldwide efforts for controlling the
pandemic, the constantly rising patient load and limited personal
protective equipment supplies have overwhelmed health care
systems across the globe. However, the toll of the COVID-19
pandemic has been heavier for low- and middle-income settings,
wherein health care systems are already underfunded,
understaffed, and overstretched. Iran is one of the countries that
was hit the hardest by the COVID-19 outbreak. The first patient
with confirmed COVID-19 in Iran was reported on February
19, 2020 in the city of Qom, which is 200 km away from Tehran,
the capital city of Iran. As of December 11, 2020, 1,092,407
patients with confirmed COVID-19 and 51,727 deaths have
been reported in the country [7]. Iran’s initial response to the
pandemic included physical distancing control policies that
aimed to minimize close contact within communities, as well
as individual-level restrictions (eg, quarantine and isolation)
and community-level restrictions (eg, educational and
recreational facility closures, nonessential business closures,
and the cancellation of public/mass/crowded gatherings).
Nevertheless, economic sanctions, inadequate financial and
human resources, inefficient leadership, and limited hospital
capacities for the rapidly growing number of patients with
COVID-19 who require hospitalization have created real and
considerable challenges for controlling the epidemic [8-10]. As
>98% of the population has access to mobile or landline phones
[11], a cost-effective method for reducing the community
transmission of SARS-CoV-2 and managing the influx of
patients with COVID-19 in Iran's hospitals could be managing
discharged patients or patients with noncritical conditions via
routine telephone follow-ups. Telemedicine has been proposed
as an effective approach for responding to health emergencies.
A telemedicine approach may ensure that the limited number
of hospital beds are occupied by the people who need them
most, and provide patients and their families with access to
medical care, without unnecessary referrals to health care
facilities [12,13]. Therefore, we designed a prospective cohort
study (ie, the Tele-COVID-19 study) to follow-up with patients
with COVID-19 who have been discharged from teaching
hospitals in Tehran, to assess the overall spread of SARS-CoV-2
in the community. The specific objectives of the
Tele-COVID-19 study are as follows: (1) conduct
telephone-based follow-ups with patients who were admitted
to the coronavirus emergency departments of certain hospitals
in Tehran; (2) precisely monitor postdischarge patients’ signs
and clinical symptoms; (3) provide patients with sufficient
education on home care and isolation principles, and medical
advice on care and the proper use of drugs; (4) prevent
unnecessary hospital returns and provide timely information on
the in-household transmission of SARS-CoV-2; and (5) refer
postdischarge patients with critical conditions to the emergency
department in a timely manner, and facilitate patient readmission
when necessary. Herein, we present the overall characteristics
of the Tele-COVID-19 cohort and the preliminary baseline




The Tele-COVID-19 study is a prospective cohort study that
was designed to follow-up with postdischarge patients with
COVID-19 for a 2-week period in Tehran, Iran. At baseline,
data collection was completed by a medical student volunteer
group, which was established on February 22, 2020 under the
supervision of clinical professors [14]. Baseline data collection
was conducted from March 9, 2020 to May 20, 2020. Given the
prospective nature of the cohort, a top-up sample of participants
will be included in the sampling frame during subsequent waves
of data collection. Due to the emerging nature of SARS-CoV-2,
a prospective sample size was not calculated. Additionally,
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because the recruitment of patients depends on the spread of
COVID-19 in Tehran, there is no specific end date for
recruitment at this point in time.
Setting
In total, 4 major teaching hospitals in Tehran (ie, Shohada
Tajrish Hospital, Ayatollah Taleghani Hospital, Shahid
Modarres Hospital, and Loghman Hakim Hospital) were
included at baseline. Collectively, these hospitals have 1652
beds, 136 primary care clinics, more than 100 specialties, and
over 3000 employees. Of these 4 hospitals, 3 are located in the
northern districts of Tehran and 1 is located in the southern
district (Figure 1).
Figure 1. Hospitals included in the first phase of recruitment for the Tele-COVID-19 cohort.
Eligibility Criteria
Eligible participants were hospitalized adults (ie, aged >18
years) with COVID-19. Patients who tested positive for
SARS-CoV-2 infection in polymerase chain reaction tests, and
those who were treated and discharged from COVID-19 wards
were recruited into the cohort. Participants were excluded if
their contact information was wrong or missing. All patients
who did not respond to follow-up phone calls or declined to
provide consent were also excluded. Participants were briefed
about this study’s aims and objectives via in-person discussions
in the hospital and postdischarge phone calls. All participants
provided verbal consent, and each patient received a unique
national identification code to avoid potential biases that could
arise from patients who went to several other health care
facilities postdischarge.
Data Collection
At baseline, telephone follow-ups, which were led by volunteer
medical students, were conducted on postdischarge days 1-3,
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5, 7, 10, and 14, in accordance with a predetermined protocol
and under the supervision of clinical professors. The calls were
made to patients’ cell phones or landline phones from 10 AM
to 4 PM. In the case of a nonresponse, calls were repeated 3
times at 2-hour intervals until the end of the calling time.
Patients were excluded if they could not be reached by the end
of the day. The first round of interviews was conducted by
medical clerks. If a patient was assessed to have a concerning
or critical condition, a follow-up phone call was made by a
senior medical intern after consulting clinical professors for
further assessment. Data were recorded on a secure and
password-protected web-based platform. Each medical clerk
signed a nondisclosure agreement before the enrollment period,
to ensure that data remained secure and confidential. Medical
clerks could only observe the data that they themselves
collected; they could not observe the data that other team
members collected. By the end of each patient’s 14-day
follow-up period, all data were extracted from the web-based
platform and stored on a password-protected external hard drive.
Data were collected by using a pilot-tested, comprehensive
COVID-19 risk assessment questionnaire. The development of
the questionnaire was informed by the Center for Disease
Control and Prevention and the national guidelines of the
Ministry of Health and Medical Education, and included the
following areas: sociodemographic information (eg, age and
sex), a history of potential exposure to SARS-CoV-2 (eg, a
travel history to China or the city of Qom and a history of
exposure to patients with COVID-19), signs and clinical
symptoms (eg, fever, dry cough, dyspnea, nausea, and diarrhea),
a medical history of underlying conditions (eg, a history of
diabetes, cardiovascular disorders, chronic lung disease, chronic
renal disease, and immunodeficiency), habitual history (eg,
current smoker, former smoker, and nonsmoker), prescribed
drugs at postdischarge (eg, hydroxychloroquine and
lopinavir/ritonavir), a history of non-COVID-19–related
medications (eg, nonsteroidal anti-inflammatory drugs and
statin), and household information on close contacts (eg,
high-risk household contacts and household transmissions).
Interview Process
Interviewers were enrolled if they were fourth-year to
seventh-year medical students and registered in their respective
medical schools at the time of interviews. There were 2 main
groups of interviewers, as follows: (1) medical clerks (ie, those
in their fourth and fifth years of training) and (2) medical interns
(ie, those in their sixth and seventh years of training). Under
the supervision of clinical professors, medical interns were
mentored by faculty staff. Medical interns also helped with
supervising the medical clerks. All interviewers completed a
40-hour crash course. The educational topics in the course were
tailored toward COVID-19–related prevention, care, and
treatment. The topics included methods for taking a complete
history, methods for conducting complete physical examinations,
essential practices for COVID-19, guidance on precautionary
measures for providing home care and isolating patients and
other household members, and the assessment of high-risk
conditions (ie, interviewers were given a referral guide for each
medical condition). Data collection procedures were pilot-tested
with patients through role play to ensure that data were collected
consistently. During the phone calls, patients and their household
members were educated on home care procedures and isolation
guidelines. All clinical signs and symptoms were closely
examined and recorded. Treatment regimens and procedures
were adjusted accordingly, and patients were instructed to stay
at home or return to the emergency room if they or their
household members exhibited critical symptoms.
Statistical Analysis
Data entries were double-checked and cleaned by using STATA
version 15 (StataCorp LLC). For the purposes of this prospective
cohort study, descriptive statistics, including relative frequencies
for categorical variables and means and standard deviations for
quantitative variables, were reported. However, for the purposes
of future studies that derive data from our cohort, associations
will be examined by using appropriate regression analyses.
Ethics
The study protocol was reviewed and approved by the ethics
committee of the Shahid Beheshti University of Medical
Sciences (Ethics approval reference number:
IR.SBMU.RETECH.REC.1399.114).
Results
Of the 950 patients with confirmed COVID-19 who were
approached at the initial phase of the Tele-COVID-19 study,
823 (86.6%) consented and were successfully enrolled in this
study. Of the 823 participants, 261 (31.7%) were from Shohada
Tajrish Hospital, 213 (25.9%) were from Loghman Hakim
Hospital, 233 (28.3%) were from Ayatollah Taleghani Hospital,
and 116 (14.1%) were from Shahid Modarres Hospital. The
baseline characteristics of the enrolled patients are presented in
Table 1.
Of the 823 participants, 449 (54.5%) were male. The mean age
of participants was 50.1 years (SD 12.6 years). Overall, 65
(65/821, 7.9%) participants were health care workers, and 19
(19/821, 2.3%) participants reported that they travelled to known
epicenters of COVID-19 within the previous 14 days of the
interview. A total of 471 (471/818, 57.6%) reported that they
were exposed to a patient with COVID-19 within the past 14
days of the interview. A total of 701 (701/814, 86.2%) patients
visited a hospital due to suspicious signs and symptoms, and
59 (59/814, 7.2%) patients sought medical attention due to being
exposed to people with probable COVID-19. Overall, 167
(167/811, 20.6%) were current/former smokers. Most patients
did not have any underlying diseases (372/676, 55%), and only
25 (25/818, 3.1%) were immunodeficient. The mean length of
hospitalization was 5.23 days (SD 4 days).
Detailed data on baseline clinical symptoms was available for
676 patients. Among the baseline clinical symptoms, the 3 most
common symptoms were cough (466/676, 68.9%), respiratory
distress (394/676, 58.3%), and fever (364/676, 53.8%). Only a
small proportion of patients (29/676, 4.3%) had severe
conditions (ie, admitted to an intensive care unit or had an
oxygen saturation level of <90%). Most patients reported that
they would be able to self-isolate at postdischarge (565/676,
83.5%).
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Table 1. Baseline characteristics of patients with COVID-19 from the Tele-COVID-19 cohort in Tehran, Iran.
ValueCharacteristics
Number of patients from each hospital (N=823), n (%)a
213 (25.9)Loghman Hakim Hospital
261 (31.7)Shohada Tajrish Hospital
116 (14.1)Shahid Modarres Hospital
233 (28.3)Ayatollah Taleghani Hospital
Sex (N=823), n (%)a
449 (54.6)Male
374 (45.4)Female
50.1 (12.6)Age (years; N=823), mean (SD)
Health care worker (N=821), n (%)a
65 (7.9)Yes
756 (92.1)No




802 (97.6)No travel history
Exposure to patients with confirmed COVID-19 in the previous 14 days (N=818), n (%)a
176 (21.5)Yes
642 (78.5)No
Reason for hospital visit (N=814), n (%)a
701 (86.2)Suspicious clinical signs and symptoms
59 (7.2)Exposure to a probable COVID-19 patient
54 (6.6)Other




Chronic respiratory conditionsb (N=818), n (%)a
81 (9.9)Yes
737 (90.1)No
Diabetes mellitus (N=820), n (%)a
159 (19.4)Yes
661 (80.6)No
Cardiovascular conditions (N=817), n (%)a
181 (22.2)Yes
636 (77.8)No
Chronic renal conditions (N=821), n (%)a
57 (6.9)Yes
764 (93.1)No
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Chronic liver conditions (N=821), n (%)a
23 (2.8)Yes
798 (97.2)No
Immunodeficiency (N=818), n (%)a
25 (3.1)Yes
793 (96.9)No
Underlying neurological conditionsc (N=819), n (%)a
52 (6.5)Yes
767 (93.5)No
5.32 (4)Number of hospitalization days, mean (SD)







270 (39.9)Nausea and vomiting
239 (35.4)Diarrhea
289 (42.8)Loss of appetite







COVID-19 severityd (N=676), n (%)a
647 (95.7%)Mild to moderate
29 (4.3%)Severe
aPercentages are rounded to 1 decimal point.
bChronic respiratory conditions include asthma, emphysema, and chronic obstructive pulmonary disease.
cUnderlying medical conditions include chronic neurological diseases and neurodevelopmental/intellectual disability.
dSevere cases included people who were admitted to the intensive care unit or had an oxygen saturation level of <90%.
During the initial data collection phase, more than 5000 phone
calls were made. Overall, 577 reports were recorded in the daily
critical case report sheets. Patients with critical conditions were
directly followed by medical interns and clinical professors for
more specific medical care. Patients with serious conditions
(n=69) were referred to the emergency department, in
accordance with hospital staff recommendations. Of these 69
patients, 40 (58%) were rehospitalized. Patients with minor
conditions who primarily intended to revisit a hospital were
successfully managed over the phone, leading to the prevention
of unnecessary hospital visits (296/823, 36%). A total of 60
(60/823, 7.3%) patients who reported that they were




The Tele-COVID-19 cohort provided a platform for effectively
following up with patients with COVID-19 after hospitalization.
Our prospective cohort study presents a cost-effective way of
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managing postdischarge patients with COVID-19 and supporting
them and their family members on their path to full recovery.
The Tele-COVID-19 cohort was designed and run by a group
of volunteer medical students, who successfully followed up
with 823 postdischarge patients with COVID-19 during the
baseline wave of this study. Given the burden of COVID-19 on
health care systems in resource-limited settings such as Iran,
telephone-based follow-up studies that involve medical students
may not only enhance patient care, but also enhance medical
education for medical students, who are often left out of the
COVID-19 response due to concerns about limited personal
protective equipment resources and students’ safety [15]. Early,
postdischarge telephone follow-up calls have previously been
shown to improve patients’ health outcomes and reduce their
chances of readmission or critical condition development in the
first month after discharge [16-19].
Limitations
We acknowledge that our study has several limitations that are
common among studies of a similar nature. First, our nonrandom
sample of participants from major hospitals in Tehran may not
be generalizable to patients with COVID-19 in other parts of
Tehran or Iran. However, it is likely that the characteristics of
the participants who were recruited into our cohort are not
considerably different from those of patients from other Tehran
hospitals that were not included in our study. Second,
participants' self-reported responses with regard to potential
risk factors or underlying comorbidities are prone to social
desirability and reporting biases. Third, we did not collect any
data on the mental health profiles of patients. This could be
considered for future waves of data collection. Fourth, most
patients in our cohort (647/676, 95.7%) exhibited mild or
moderate COVID-19 symptoms. Furthermore, these patients
had no adverse underlying conditions. Therefore, these patients
do not provide a complete clinical picture of severe COVID-19
in Tehran hospitals.
Conclusions
The Tele-COVID-19 cohort is a unique, student-led cohort that
could provide an effective platform for improving our evolving
understanding of COVID-19 care and treatment in Iran. Such
cohort studies assist the medical community by reducing the
number of medical complications among people who are
recovering from COVID-19, improving our understanding of
the clinical course of the disease, identifying potential drug
interactions and the adverse effects of pharmacotherapies,
reducing the household transmission and secondary attack rates
of SARS-CoV-2, referring discharged patients with critical
conditions to the emergency department in a timely manner,
reducing patients’ anxiety, and preventing unnecessary hospital
visits. Moreover, cohorts like the Tele-COVID-19 cohort
provide a cost-effective and rapidly implementable platform
for improving our understanding of COVID-19 in
resource-limited settings.
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